Literature DB >> 23670210

microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.

Yeqing Mao1, Hong Chen, Yiwei Lin, Xin Xu, Zhenghui Hu, Yi Zhu, Jian Wu, Xianglai Xu, Xiangyi Zheng, Liping Xie.   

Abstract

microRNAs (miRNAs), small non-coding RNAs, have emerged as key regulators of a large number of genes. The present study aimed to explore novel biological functions of miR-330 in the human prostate cancer cell lines DU145 and PC3. We confirmed that miR-330 was downregulated and inversely correlated with specificity protein 1 (Sp1) expression. Overexpression of miR-330 by transfection of a chemically synthesized miR-330 mimic induced a reduction in expression levels of the Sp1 protein, accompanied by significant suppression of cellular migration and invasion capability. In addition, the Sp1-knockdown experiments presented similar phenomena. Finally, the luciferase reporter assay validated Sp1 as the direct target of miR-330. These findings indicate that miR-330 acts as an anti-metastatic miRNA in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670210     DOI: 10.3892/or.2013.2452

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  26 in total

1.  MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4.

Authors:  Hui Meng; Kai Wang; Xuedan Chen; Xingying Guan; Liwen Hu; Gang Xiong; Juan Li; Yun Bai
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  miR-330-5p targets tyrosinase and induces depigmentation.

Authors:  Florian Rambow; Audrey Bechadergue; Gaelle Saintigny; Frédérique Morizot; Christian Mahé; Lionel Larue
Journal:  J Invest Dermatol       Date:  2014-05-26       Impact factor: 8.551

3.  Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells.

Authors:  Xiao Hu; Yujie Feng; Lin Sun; Linlin Qu; Chuandong Sun
Journal:  Dig Dis Sci       Date:  2017-01-03       Impact factor: 3.199

4.  Tumor-suppressing effects of microRNA-429 in human renal cell carcinoma via the downregulation of Sp1.

Authors:  Deyao Wu; Xiaobing Niu; Huixing Pan; Yunfeng Zhou; Zichun Zhang; Ping Qu; Jian Zhou
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

Review 5.  MicroRNA mediated therapeutic effects of natural agents in prostate cancer.

Authors:  Km Anjaly; A B Tiku
Journal:  Mol Biol Rep       Date:  2021-07-24       Impact factor: 2.316

6.  MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1.

Authors:  Jun Jiang; Xiaojuan Lv; Liang Fan; Guodong Huang; Yan Zhan; Mengyi Wang; Hongda Lu
Journal:  Tumour Biol       Date:  2014-07-11

7.  MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.

Authors:  Stephen Safe
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

8.  Impact and mechanism of non-steroidal anti-inflammatory drugs combined with chemotherapeutic drugs on human lung cancer-nude mouse transplanted tumors.

Authors:  Weiyi Sun; Gang Chen
Journal:  Oncol Lett       Date:  2016-04-25       Impact factor: 2.967

9.  MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1.

Authors:  Ming Qian; Haiyi Gong; Xinghai Yang; Jian Zhao; Wangjun Yan; Yan Lou; Dongyu Peng; Zhenxi Li; Jianru Xiao
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967

10.  Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.

Authors:  Weirong Cui; Yulan Qian; Xiaoke Zhou; Yuxin Lin; Junfeng Jiang; Jiajia Chen; Zhongming Zhao; Bairong Shen
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.